FSCAI

AcronymDefinition
FSCAIFellow of the Society for Cardiovascular Angiography and Interventions
References in periodicals archive ?
Rashmi Thapa, MD; Mazen Shaheen, MD; Dwight Dishmon, MD; Rami Khouzam, MD, FACC, FACP FASNC, FASE, FSCAI
Bilateral coronary cameral fistulae and coronary artery disease presenting in an elderly woman
Peter L Duffy, MD, MMM, FACC FSCAI, is an interventional cardiologist and founding partner of Pinehurst Cardiology Consultants in NC.
Quantifying quality care isn't easy
"This expanded indication further confirms XIENCE PRIME and XIENCE V as important options for physicians who are treating patients with diabetes," said Charles Simonton, M.D., FACC, FSCAI, divisional vice president, Medical Affairs, and chief medical officer, Abbott Vascular.
ABBOTT'S XIENCE PRIME/XIENCE V GET INDICATIONS FOR DIABETES
Denktas, FACC, FSCAI, Assistant Professor of Medicine University of Texas at Houston SB 1.246, 6431 Fannin, Houston, TX 77030 Telephone: +1 (713) 500-6590, Fax: +1 (713) 500-6556 E-mail: Ali.E.Denktas@uth.tmc.edu
Bridge over troubled coronary artery/ muscular bridge causing non-ST-segment elevation myocardial infarction/Tehlikedeki koroner arterin koprusu/ST-elevasyonsuz miyokard infarktusune neden olan miyokardiyal kopruleme
Deliargyris, MD, FACC, FESC, FSCAI, as Chief Medical Advisor.
United States : PLx Pharma Retains Dr. Efthymios N. Deliargyris as Chief Medical Advisor
Brady, ND, DC, CCN, DACBN; Tania Tyles Dempsey, MD; and Joel Kahn, MD, FACC, FACP, FSCAI.
American Academy of Anti-Aging Medicine (A4M) to Hold Gut, Brain and Autoimmune Disorders: The Role of Food Symposium August 16-17 in Los Angeles, CA
On July 12, Barry Lowell, MD, FACC, FSCAI, an interventional cardiologist with Atlantic Medical Group implanted the first stent in a patient with coronary artery disease at Morristown Medical Center.
United States : Morristown Medical Center First Hospital in New Jersey to Offer Newly Approved, Bioabsorbable Stent
Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI and chief medical officer for Okyanos Heart Institute.
Okyanos Heart Institute Chief Executive Officer to Speak at the Strategic Forum Meeting Oct. 26
"The rapid completion of enrollment in the Absorb randomized trials is a testament to the interest among doctors and patients in advancing new options to treat heart disease," said Gregg Stone, M.D., FACC, FSCAI, director, cardiovascular research and education, Center for Interventional Vascular Therapy, Columbia University Medical Center, New York-Presbyterian Hospital.
United States : Abbott Completes Enrollment of Absorb Randomized Clinical Trials in the United States, Japan and China
Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI, will present to the 2012 Transcatheter Cardiovascular Therapeutics (TCT) meeting on Tuesday, Oct.
Okyanos Heart Institute Chief Medical Officer Presents to Transcatheter Cardiovascular Therapeutics Meeting
"MitraClip is a breakthrough in the treatment of severe mitral regurgitation, a condition that is progressive and causes extreme fatigue and shortness of breath, eventually making even simple tasks virtually impossible, and increasing the risk of stroke, heart failure and death," said Ted Feldman, M.D., FSCAI, director, Cardiac Catheterization Laboratory and The Mr.
United States : Abbott's First-In-Class MitraClipA Device Now Available for U.S. Patients
Walpole Jr., M.D., MBA, FACC, FACAI, FSCAI, recently joined other top cardiologists to co-author a white paper for the American College of Cardiology.
Okyanos Heart Institute Chief Medical Officer Co-Authors American College of Cardiology White Paper
Acronyms browser ?
Full browser ?